Clinical Trial

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-02-22; most recent amendment 2024-08-19.
Trial Details
NCT Number NCT04770207
Lead Sponsor Second Affiliated Hospital of Guangzhou Medical University
Conditions Hepatocellular Carcinoma, Solid Tumor, Adult
Enrollment 100 participants
Start Date 2020-11-01
Primary Completion 2029-11-01 (estimated)
Study Completion 2035-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-21